Intrinsic cardiomyopathy in Marfan syndrome

Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans

Laurence Campens, Marjolijn Renard, Bram Trachet, Patrick Segers, Laura Muino Mosquera, Johan De Sutter, Lynn Sakai, Anne De Paepe, Julie De Backer

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background:Mild intrinsic cardiomyopathy in patients with Marfan syndrome (MFS) has consistently been evidenced by independent research groups. So far, little is known about the long-term evolution and pathophysiology of this finding.Methods:To gain more insights into the pathophysiology of MFS-related cardiomyopathy, we performed in-vivo and ex-vivo studies of 11 Fbn1 C1039G/+ mice and 9 wild-type (WT) littermates. Serial ultrasound findings obtained in mice were correlated to the human phenotype. We therefore reassessed left ventricular (LV) function parameters over a 6-y follow-up period in 19 previously reported MFS patients, in whom we documented mild LV dysfunction.Results:Fbn1 C1039G/+ mice demonstrated LV contractile dysfunction. Subsequent ex-vivo studies of the myocardium of adult mutant mice revealed upregulation of TGFβ-related pathways and consistent abnormalities of the microfibrillar network, implicating a role for microfibrils in the mechanical properties of the myocardium. Echocardiographic parameters did not indicate clinical significant deterioration of LV function during follow-up in our patient cohort.Conclusion:In analogy with what is observed in the majority of MFS patients, the Fbn1 C1039G/+ mouse model demonstrates mild intrinsic LV dysfunction. Both extracellular matrix and molecular alterations are implicated in MFS-related cardiomyopathy. This model may now enable us to study therapeutic interventions on the myocardium in MFS.

Original languageEnglish (US)
Pages (from-to)256-263
Number of pages8
JournalPediatric Research
Volume78
Issue number3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Marfan Syndrome
Cardiomyopathies
Left Ventricular Dysfunction
Myocardium
Left Ventricular Function
Microfibrils
Extracellular Matrix
Up-Regulation
Phenotype
Research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Intrinsic cardiomyopathy in Marfan syndrome : Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans. / Campens, Laurence; Renard, Marjolijn; Trachet, Bram; Segers, Patrick; Muino Mosquera, Laura; De Sutter, Johan; Sakai, Lynn; De Paepe, Anne; De Backer, Julie.

In: Pediatric Research, Vol. 78, No. 3, 01.01.2015, p. 256-263.

Research output: Contribution to journalArticle

Campens, L, Renard, M, Trachet, B, Segers, P, Muino Mosquera, L, De Sutter, J, Sakai, L, De Paepe, A & De Backer, J 2015, 'Intrinsic cardiomyopathy in Marfan syndrome: Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans', Pediatric Research, vol. 78, no. 3, pp. 256-263. https://doi.org/10.1038/pr.2015.110
Campens, Laurence ; Renard, Marjolijn ; Trachet, Bram ; Segers, Patrick ; Muino Mosquera, Laura ; De Sutter, Johan ; Sakai, Lynn ; De Paepe, Anne ; De Backer, Julie. / Intrinsic cardiomyopathy in Marfan syndrome : Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans. In: Pediatric Research. 2015 ; Vol. 78, No. 3. pp. 256-263.
@article{de3d23615b2a4caaa6f84bc12256851f,
title = "Intrinsic cardiomyopathy in Marfan syndrome: Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans",
abstract = "Background:Mild intrinsic cardiomyopathy in patients with Marfan syndrome (MFS) has consistently been evidenced by independent research groups. So far, little is known about the long-term evolution and pathophysiology of this finding.Methods:To gain more insights into the pathophysiology of MFS-related cardiomyopathy, we performed in-vivo and ex-vivo studies of 11 Fbn1 C1039G/+ mice and 9 wild-type (WT) littermates. Serial ultrasound findings obtained in mice were correlated to the human phenotype. We therefore reassessed left ventricular (LV) function parameters over a 6-y follow-up period in 19 previously reported MFS patients, in whom we documented mild LV dysfunction.Results:Fbn1 C1039G/+ mice demonstrated LV contractile dysfunction. Subsequent ex-vivo studies of the myocardium of adult mutant mice revealed upregulation of TGFβ-related pathways and consistent abnormalities of the microfibrillar network, implicating a role for microfibrils in the mechanical properties of the myocardium. Echocardiographic parameters did not indicate clinical significant deterioration of LV function during follow-up in our patient cohort.Conclusion:In analogy with what is observed in the majority of MFS patients, the Fbn1 C1039G/+ mouse model demonstrates mild intrinsic LV dysfunction. Both extracellular matrix and molecular alterations are implicated in MFS-related cardiomyopathy. This model may now enable us to study therapeutic interventions on the myocardium in MFS.",
author = "Laurence Campens and Marjolijn Renard and Bram Trachet and Patrick Segers and {Muino Mosquera}, Laura and {De Sutter}, Johan and Lynn Sakai and {De Paepe}, Anne and {De Backer}, Julie",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/pr.2015.110",
language = "English (US)",
volume = "78",
pages = "256--263",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Intrinsic cardiomyopathy in Marfan syndrome

T2 - Results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans

AU - Campens, Laurence

AU - Renard, Marjolijn

AU - Trachet, Bram

AU - Segers, Patrick

AU - Muino Mosquera, Laura

AU - De Sutter, Johan

AU - Sakai, Lynn

AU - De Paepe, Anne

AU - De Backer, Julie

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background:Mild intrinsic cardiomyopathy in patients with Marfan syndrome (MFS) has consistently been evidenced by independent research groups. So far, little is known about the long-term evolution and pathophysiology of this finding.Methods:To gain more insights into the pathophysiology of MFS-related cardiomyopathy, we performed in-vivo and ex-vivo studies of 11 Fbn1 C1039G/+ mice and 9 wild-type (WT) littermates. Serial ultrasound findings obtained in mice were correlated to the human phenotype. We therefore reassessed left ventricular (LV) function parameters over a 6-y follow-up period in 19 previously reported MFS patients, in whom we documented mild LV dysfunction.Results:Fbn1 C1039G/+ mice demonstrated LV contractile dysfunction. Subsequent ex-vivo studies of the myocardium of adult mutant mice revealed upregulation of TGFβ-related pathways and consistent abnormalities of the microfibrillar network, implicating a role for microfibrils in the mechanical properties of the myocardium. Echocardiographic parameters did not indicate clinical significant deterioration of LV function during follow-up in our patient cohort.Conclusion:In analogy with what is observed in the majority of MFS patients, the Fbn1 C1039G/+ mouse model demonstrates mild intrinsic LV dysfunction. Both extracellular matrix and molecular alterations are implicated in MFS-related cardiomyopathy. This model may now enable us to study therapeutic interventions on the myocardium in MFS.

AB - Background:Mild intrinsic cardiomyopathy in patients with Marfan syndrome (MFS) has consistently been evidenced by independent research groups. So far, little is known about the long-term evolution and pathophysiology of this finding.Methods:To gain more insights into the pathophysiology of MFS-related cardiomyopathy, we performed in-vivo and ex-vivo studies of 11 Fbn1 C1039G/+ mice and 9 wild-type (WT) littermates. Serial ultrasound findings obtained in mice were correlated to the human phenotype. We therefore reassessed left ventricular (LV) function parameters over a 6-y follow-up period in 19 previously reported MFS patients, in whom we documented mild LV dysfunction.Results:Fbn1 C1039G/+ mice demonstrated LV contractile dysfunction. Subsequent ex-vivo studies of the myocardium of adult mutant mice revealed upregulation of TGFβ-related pathways and consistent abnormalities of the microfibrillar network, implicating a role for microfibrils in the mechanical properties of the myocardium. Echocardiographic parameters did not indicate clinical significant deterioration of LV function during follow-up in our patient cohort.Conclusion:In analogy with what is observed in the majority of MFS patients, the Fbn1 C1039G/+ mouse model demonstrates mild intrinsic LV dysfunction. Both extracellular matrix and molecular alterations are implicated in MFS-related cardiomyopathy. This model may now enable us to study therapeutic interventions on the myocardium in MFS.

UR - http://www.scopus.com/inward/record.url?scp=84939488878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939488878&partnerID=8YFLogxK

U2 - 10.1038/pr.2015.110

DO - 10.1038/pr.2015.110

M3 - Article

VL - 78

SP - 256

EP - 263

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 3

ER -